renin-angiotensin-aldosterone system inhibitor treatmentCKDchronic kidney diseasetype 2 diabetescardiovascular diseasehypertension
…wo eGFR measurements or only two eGFR measurements, followed by renin-angiotensin-aldosterone system inhibitor treatment in newly diagnosed eligible patients). The economic burden esti…